Analystreport

Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Arrowhead Pharmaceuticals, Inc.  (ARWR) 
Last arrowhead pharmaceuticals, inc. earnings: 2/5 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.arrowheadpharma.com/investor-relations